Solid Tumor Clinical Trials Database - Free Access to 440 Studies
Access comprehensive clinical trial information for Solid Tumor through Pure Global AI's free database. This collection includes 440 clinical trials across multiple phases including Phase 1, N/A, Phase 2. Currently, 166 trials are actively recruiting participants.
Research for Solid Tumor is being conducted in China, United States of America, Japan and 7+ other countries. Leading sponsors include Jiangsu HengRui Medicine Co., Ltd. and Eli Lilly and Company. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients
Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors
A Phase 1/2 Study of PBI-410 in Advanced Solid Tumors
PD-L1 Specific [68Ga]-Nb-1 Nanobody Probe for PET Imaging in Solid Tumors
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors
Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
HS-IT101 Injection in the Treatment of Advanced Solid Tumors
An Exploratory Study by Fast CAR T Cells
A Study on Tuvusertib (Oral ATR Inhibitor) in Combination With PLX038 (Topo1 Inhibitor) in Patients With Advanced Solid Tumors
What Unmet Need for the Patients?A Focus on the Social Determinants of Health in Phase 1 Clinical Trials
Online Proton Adaptive Radiotherapy
M1774 Human Mass Balance Study (DDRIVER Solid Tumors 303)
Study of STP938 in Advanced Solid Tumours
Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications
Study of 23ME-01473 in Patients With Advanced Solid Malignancies
An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells
Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors
Pure Global AI provides free access to 440 clinical trials studying Solid Tumor, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Jiangsu HengRui Medicine Co., Ltd., Eli Lilly and Company, Hoffmann-La Roche, among others.